CVS Health, iRobot, Vaxart & more

Check out some of the largest moving companies on the pre-market:

CVS Health (CVS) – The drugstore and pharmacy services management company earned $ 2.04 per share for the first quarter, above the consensus estimate of $ 1.72 per share. Revenues were also above Wall Street forecasts. CVS saw higher sales in its stores, with customer traffic spurred by vaccination visits with Covid-19. CVS also raised its guidance for the full year, and its stocks rose 3% ahead of the market.

iRobot (IRBT) – iRobot earned 41 cents per share in the first quarter, compared to a consensus estimate of 9 cents per share. Revenue from the maker of the Roomba robotic vacuum cleaner also beat estimates, however its stock fell 8.6% in the pre-market on concerns about shipping and component costs.

Pfizer (PFE) – The drug maker beat estimates by 16 cents per share with quarterly earnings of 93 cents per share. Revenue was also above forecasts, and the company raised its guidance for the full year as sales of its Covid-19 vaccine continued to be stronger than expected. In addition, the Food and Drug Administration is due to approve the vaccine for use in adolescents ages 12-15, according to federal officials familiar with the plan and who have spoken to the New York Times. Pfizer shares rose 1.3% in premarket trading.

Vaxart (VXRT) – Vaxart gained 18.6% in premarket sales after reporting positive results in a Phase 1 study of its Covid-19 oral vaccine. According to Vaxart, the vaccine could be as effective as the injected vaccines developed by Pfizer and Moderna (MRNA).

Under Armor (UAA) – The sportswear maker’s stock rose 2.8% prior to entering the market after posting earnings of 16 cents per share in the first quarter, well above the consensus estimate of 3 cents per share. Revenue also beat analysts’ forecasts, and Under Armor raised its full-year outlook as the reopening of markets fueled demand for footwear and apparel. Separately, the company agreed to pay $ 9 million to settle a Securities and Exchange Commission investigation into its accounts.

DuPont (DD) – The industrial materials maker reported quarterly earnings of 91 cents per share, 15 cents per share above estimates. Revenue also exceeded analysts’ forecasts. DuPont sees strong demand for its products from semiconductor manufacturers as well as the automotive markets, and the company has raised its profit and revenue guidance for the full year.

XPO Logistics (XPO) – XPO reported quarterly earnings of $ 1.46 per share, well above the consensus estimate of 97 cents per share. The transportation company’s revenue was also above Wall Street forecasts and hit record levels contrary to the usual seasonal trends. XPO also increased its guidance for the full year but lost 1.2% in pre-market business.

Avis Budget (CAR) – Avis Budget lost 46 cents per share in the first quarter, less than analysts’ predicted loss of $ 2.16 per share. The car rental company’s revenue also surpassed Wall Street’s projections amid a surge in demand and more solid rental car pricing. Despite the positive results, the share fell 1.4% in the pre-market.

Qiagen (QGEN) – Qiagen posted better-than-expected earnings and sales in the most recent quarter as the genetic testing company saw rising demand for non-coronavirus products and a strong strength in its Covid-19 testing business.

SmileDirectClub (SDC) – SmileDirectClub announced that its quarterly revenue will be impacted by a cyber attack in April costing between $ 10 million and $ 15 million. The tooth alignment system maker said it successfully blocked the attack and returned its systems to normal. The share lost 9.2% in the pre-market. (Disclosure: NBC Nightly News investigated SmileDirectClub’s customer complaints in February, accusing NBCUniversal of providing false information about the company and filing a $ 2.85 billion defamation.)

Domtar (UFS) – Domtar shares rose 16.1% in the pre-market after Bloomberg reported that Canada’s Paper Excellence is considering a deal to buy its paper and packaging rival in the US. A deal could value Domtar in the mid-range of $ 50 per share, compared to Monday’s close of trading of $ 40.52 per share.

Comments are closed.